Cargando…

Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease

PURPOSE: The purpose of this study was to investigate the relationship between serum levels of lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) and the progression of coronary artery disease (CAD). MATERIALS AND METHODS: According to the inclusion criteria, exclusion criter...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Hui, Dai, Daopeng, Wang, Wencheng, Zhu, Jinzhou, Zhu, Zhengbin, Lu, Lin, Zhang, Ruiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562274/
https://www.ncbi.nlm.nih.gov/pubmed/34805864
http://dx.doi.org/10.1016/j.jimed.2019.05.005
_version_ 1784593229935542272
author Han, Hui
Dai, Daopeng
Wang, Wencheng
Zhu, Jinzhou
Zhu, Zhengbin
Lu, Lin
Zhang, Ruiyan
author_facet Han, Hui
Dai, Daopeng
Wang, Wencheng
Zhu, Jinzhou
Zhu, Zhengbin
Lu, Lin
Zhang, Ruiyan
author_sort Han, Hui
collection PubMed
description PURPOSE: The purpose of this study was to investigate the relationship between serum levels of lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) and the progression of coronary artery disease (CAD). MATERIALS AND METHODS: According to the inclusion criteria, exclusion criteria, diagnostic criteria, angiography results, and the random matching scheme, the enrolled patients were divided into the following two groups: the progression-free group (n = 47) and the progression group (n = 15). The baseline characteristics and various biochemical parameters were obtained from the medical records and medical history. Serum LPL, HL, and EL levels were detected by ELISA. The correlation between serum LPL, HL, and EL levels and coronary lesions was statistically analyzed with SPSS software. RESULTS: Significant differences were observed in serum levels of HL and EL between the progression-free group and the progression group (HL, 75.5 ± 39.2 ng/mL vs. 125.1 ± 42.1 ng/mL, P < 0.05; EL, 139.2 ± 59.6 pg/mL vs. 175.1 ± 40.1 pg/mL, P < 0.05), while the difference in the LPL level was not significant (P > 0.05). Receiver operating characteristic curve (ROC) analysis showed that the area under the curve (AUC) values of LPL, HL, and EL were 0.506 (95% CI: 0.369–0.642, P = 0.9470), 0.792 (95% CI: 0.664–0.888, P < 0.0001), and 0.693 (95% CI: 0.553–0.811, P = 0.0095), respectively. Additionally, logistic regression analysis showed that the serum level of HL was an independent risk factor for coronary artery lesion progression. CONCLUSION: Serum levels of EL and HL, but not the serum level of LPL, were positively correlated with the progression of CAD. The serum level of HL was an independent risk factor for the progression of CAD, while the serum level of EL or LPL was not an independent risk factor for the progression of CAD. For the diagnosis of CAD progression, the serum level of HL was better than the serum level of EL or LPL.
format Online
Article
Text
id pubmed-8562274
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-85622742021-11-19 Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease Han, Hui Dai, Daopeng Wang, Wencheng Zhu, Jinzhou Zhu, Zhengbin Lu, Lin Zhang, Ruiyan J Interv Med Article PURPOSE: The purpose of this study was to investigate the relationship between serum levels of lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) and the progression of coronary artery disease (CAD). MATERIALS AND METHODS: According to the inclusion criteria, exclusion criteria, diagnostic criteria, angiography results, and the random matching scheme, the enrolled patients were divided into the following two groups: the progression-free group (n = 47) and the progression group (n = 15). The baseline characteristics and various biochemical parameters were obtained from the medical records and medical history. Serum LPL, HL, and EL levels were detected by ELISA. The correlation between serum LPL, HL, and EL levels and coronary lesions was statistically analyzed with SPSS software. RESULTS: Significant differences were observed in serum levels of HL and EL between the progression-free group and the progression group (HL, 75.5 ± 39.2 ng/mL vs. 125.1 ± 42.1 ng/mL, P < 0.05; EL, 139.2 ± 59.6 pg/mL vs. 175.1 ± 40.1 pg/mL, P < 0.05), while the difference in the LPL level was not significant (P > 0.05). Receiver operating characteristic curve (ROC) analysis showed that the area under the curve (AUC) values of LPL, HL, and EL were 0.506 (95% CI: 0.369–0.642, P = 0.9470), 0.792 (95% CI: 0.664–0.888, P < 0.0001), and 0.693 (95% CI: 0.553–0.811, P = 0.0095), respectively. Additionally, logistic regression analysis showed that the serum level of HL was an independent risk factor for coronary artery lesion progression. CONCLUSION: Serum levels of EL and HL, but not the serum level of LPL, were positively correlated with the progression of CAD. The serum level of HL was an independent risk factor for the progression of CAD, while the serum level of EL or LPL was not an independent risk factor for the progression of CAD. For the diagnosis of CAD progression, the serum level of HL was better than the serum level of EL or LPL. KeAi Publishing 2019-06-27 /pmc/articles/PMC8562274/ /pubmed/34805864 http://dx.doi.org/10.1016/j.jimed.2019.05.005 Text en © 2019 Shanghai Journal of Interventional Medicine Press. Production and hosting by Elsevier B.V. on behalf of KeAi. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Han, Hui
Dai, Daopeng
Wang, Wencheng
Zhu, Jinzhou
Zhu, Zhengbin
Lu, Lin
Zhang, Ruiyan
Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
title Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
title_full Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
title_fullStr Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
title_full_unstemmed Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
title_short Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
title_sort impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562274/
https://www.ncbi.nlm.nih.gov/pubmed/34805864
http://dx.doi.org/10.1016/j.jimed.2019.05.005
work_keys_str_mv AT hanhui impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease
AT daidaopeng impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease
AT wangwencheng impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease
AT zhujinzhou impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease
AT zhuzhengbin impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease
AT lulin impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease
AT zhangruiyan impactofserumlevelsoflipoproteinlipasehepaticlipaseandendotheliallipaseontheprogressionofcoronaryarterydisease